Companies /Healthcare

Zimmer Biomet Holdings Inc

NYSE: ZBH Medical Devices
$99.50
▲ $0.10 (+0.10%) today
Markets closed · 4:40am ET
Today · % change

24/7 Wall St. View

Fundamentals

Market Cap
$19.0B
P/E Ratio
24.2
Dividend Yield
0.96%
Profit Margin
9.5%
Revenue (TTM)
$8.5B
EPS (TTM)
$4.10
52-Week Range
$79 – $106
Street Target
$107.57

About Zimmer Biomet

Zimmer Biomet Holdings Inc is a global leader in medical technology, specializing in designing and manufacturing orthopedic reconstructive products, including knee and hip replacements. Beyond joint reconstruction, their portfolio extends to sports medicine, biologics, and products for facial and skull reconstruction, as well as solutions for chest deformities. They are also innovators in robotic and surgical technologies. Founded in 1927 and based in Warsaw, Indiana, Zimmer Biomet is dedicated to enhancing patient care by providing advanced solutions for bone, joint, and soft tissue conditions, serving specialists, hospitals, and healthcare providers worldwide.

ZBH Coverage